John F Doane1, Randolph T Jackson. 1. Department of Ophthalmology, University of Kansas, Kansas City, MO, USA. jdoane@discovervision.com
Abstract
PURPOSE OF REVIEW: To review the development, design and clinical implications of the first US Food and Drugs Administration approved accommodative lens. To inform the reader of forthcoming accommodative intraocular lens technologies that are being clinically tested and other technologies that are under design. RECENT FINDINGS: We present clinical data that are currently available or pending release on accommodative intraocular lenses. As much as the results of the technology can be appreciated, the approach toward the refractive mindset of the presbyopic intraocular lens patient must be understood and mastered. SUMMARY: Accommodative intraocular lens design and development are at a feverish pace. The lure is the perceived holy grail for the solution of presbyopia.
PURPOSE OF REVIEW: To review the development, design and clinical implications of the first US Food and Drugs Administration approved accommodative lens. To inform the reader of forthcoming accommodative intraocular lens technologies that are being clinically tested and other technologies that are under design. RECENT FINDINGS: We present clinical data that are currently available or pending release on accommodative intraocular lenses. As much as the results of the technology can be appreciated, the approach toward the refractive mindset of the presbyopic intraocular lens patient must be understood and mastered. SUMMARY: Accommodative intraocular lens design and development are at a feverish pace. The lure is the perceived holy grail for the solution of presbyopia.
Authors: Mohammad Mehdi Sadoughi; Bahram Einollahi; Danial Roshandel; Mohammad Sarimohammadli; Sepehr Feizi Journal: J Ophthalmic Vis Res Date: 2015 Oct-Dec